2012 Midyear Clinical Meeting
Click here to go to the previous page
Pain, Sedation, and Delirium in the ICU: Cutting-Edge Updates
Track:
Education Sessions (CE)
Program Code: 229-L01
Date: Monday, December 3, 2012
Time: 2:00 PM to 3:30 PM EST
Location:
Breakers C, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Gilles Fraser,
PharmD, FCCM, Clinical Pharmacist in Critical Care,
Maine Medical Center
|
Gil Fraser is a Clinical Pharmacist in Critical Care at Maine Medical Center and a Professor of Medicine, Tufts University School of Medicine. He is well published with a research emphasis on treatment of the critically ill.
|
Kevin Anger,
PharmD, BCPS, Clinical Pharmacy Specialist in Critical Care,
Brigham and Women's Hospital
|
Kevin is Clinical Pharmacy Specialist in Critical Care at Brigham and Women's Hospital (BWH) in Boston M.A. where he maintains a practice site in the medical intensive care unit. Kevin is actively involved in bedside education as a PGY-1 and PGY-2 residency preceptor at BWH, and student preceptor for Northeastern University's Bouve' College of Pharmacy. Kevin is a board certified pharamcotherapy specialist, and is involved in outcomes based research in the field of critical care, where he focuses on management of pain, agitation, and delirium.
|
Joseph Dasta,
MSc, Adjunct Professor,
The University of Texas
|
Professor Dasta received his B.Sc. in Pharmacy in 1974 from West Virginia University School of Pharmacy and M.Sc. and residency in Hospital Pharmacy from The Ohio State University (OSU) in 1976. He began his academic career at OSU and developed one of the first practice sites and post-doctoral residency and fellowship programs in critical care pharmacy. He has trained eleven residents and nine fellows and many are prominent practitioners, researchers, and leaders in the profession and the pharmaceutical industry.
Professor Dasta was a member of the Society of Critical Care Medicine (SCCM) council, the governing body of SCCM, from 2007-2010. He is a fellow of the American College of Clinical Pharmacy and the American College of Critical Care Medicine. SCCM honored him by creating the Joseph F. Dasta Critical Care Pharmacy Outcomes Research Grant in 2000. Professor Dasta received the 2010 SCCM Distinguished Investigator Award and was the first pharmacist to receive this honor. Professor Dasta was the recipient of the American College of Clinical Pharmacy Education Award in 2002 and the 2010 recipient of the Sustained Contributions to the Literature Award by American Society of Health-System Pharmacists. He serves on the editorial board of Critical Care Medicine and Annals of Pharmacotherapy. Professor Dasta has over 250 peer-reviewed publications, abstracts, brief communications, and book chapters on topics including sedation, analgesia, acute hypertension, hyponatremia, sepsis, acute kidney insufficiency, acute heart failure, pharmacoeconomics, and medication safety of acute care pharmaceuticals. He has also given over 250 lectures on various topics related to critical care and health outcomes.
|
John Devlin,
PharmD, Associate Professor of Pharmacy,
Northeastern University
|
John W. Devlin, PharmD, FCCM, FCCP is an associate professor of pharmacy at Northeastern University, an adjunct associate professor of medicine at Tufts University, a member of the special and scientific staff in the Division of Pulmonary, Critical Care and Sleep Medicine and a clinical pharmacist in the medical ICU at Tufts Medical Center, Boston, MA. Dr. Devlin currently directs a critical care pharmacy fellowship program has published more than 90 peer-reviewed papers and textbook chapters and presented more than 80 research abstracts. He is a member of the editorial board of both Critical Care Medicine and Pharmacotherapy. His federally-funded research program is primarily focused on the detection and treatment of delirium in the ICU and the use and assessment of sedation in the critically ill.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Kevin Anger,
PharmD, BCPS, Clinical Pharmacy Specialist in Critical Care,
Brigham and Women's Hospital
|
Kevin is Clinical Pharmacy Specialist in Critical Care at Brigham and Women's Hospital (BWH) in Boston M.A. where he maintains a practice site in the medical intensive care unit. Kevin is actively involved in bedside education as a PGY-1 and PGY-2 residency preceptor at BWH, and student preceptor for Northeastern University's Bouve' College of Pharmacy. Kevin is a board certified pharamcotherapy specialist, and is involved in outcomes based research in the field of critical care, where he focuses on management of pain, agitation, and delirium.
|
Description
Management of Pain in the ICU, Gilles L. Fraser, PharmD, FCCM
Management of Sedation in the ICU, Joseph F. Dasta, MSc
Management of Delirium in the ICU, John W. Devlin, PharmD
- Describe key pharmacotherapy concepts and barriers to optimizing pain, sedation, and delirium pharmacotherapy in critically ill patients.
- Discuss key concepts in the selection of sedatives, analgesics, and anti-psychotic agents in critically ill patients.
- Evaluate recent literature on the management of pain, sedation, and delirium in the ICU.
